178 related articles for article (PubMed ID: 16076755)
1. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells.
Varshney R; Dwarakanath B; Jain V
Int J Radiat Biol; 2005 May; 81(5):397-408. PubMed ID: 16076755
[TBL] [Abstract][Full Text] [Related]
2. 2-Deoxy-D-glucose and 6-aminonicotinamide-mediated Nrf2 down regulation leads to radiosensitization of malignant cells via abrogation of GSH-mediated defense.
Sharma PK; Varshney R
Free Radic Res; 2012 Dec; 46(12):1446-57. PubMed ID: 22946929
[TBL] [Abstract][Full Text] [Related]
3. Contribution of oxidative stress to radiosensitization by a combination of 2-DG and 6-AN in human cancer cell line.
Varshney R; Adhikari JS; Dwarakanath BS
Indian J Exp Biol; 2003 Dec; 41(12):1384-91. PubMed ID: 15320490
[TBL] [Abstract][Full Text] [Related]
4. Differential modification of radiation damage in 5-bromo-2-deoxy-uridine sensitized human glioma cells and PHA-stimulated peripheral leukocytes by 2-deoxy-D-glucose.
Kalia VK; Devi NK
Indian J Exp Biol; 1994 Sep; 32(9):637-42. PubMed ID: 7814043
[TBL] [Abstract][Full Text] [Related]
5. Metabolic oxidative stress induced by a combination of 2-DG and 6-AN enhances radiation damage selectively in malignant cells via non-coordinated expression of antioxidant enzymes.
Sharma PK; Bhardwaj R; Dwarakanath BS; Varshney R
Cancer Lett; 2010 Sep; 295(2):154-66. PubMed ID: 20363070
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.
Kalia VK; Prabhakara S; Narayanan V
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S57-60. PubMed ID: 20009297
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of radiation effects in plateau phase human glioma cells by combination of metabolic inhibitors.
Kalia VK
Indian J Exp Biol; 1993 Apr; 31(4):312-5. PubMed ID: 8359829
[TBL] [Abstract][Full Text] [Related]
8. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
Dwarakanath BS; Adhikari JS; Jain V
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1125-33. PubMed ID: 10192364
[TBL] [Abstract][Full Text] [Related]
9. Alterations in radiation induced cell cycle perturbations by 2-deoxy-D-glucose in human tumor cell lines.
Adhikari JS; Dwarakanath BS; Mathur R; Ravindranath T
Indian J Exp Biol; 2003 Dec; 41(12):1392-9. PubMed ID: 15320491
[TBL] [Abstract][Full Text] [Related]
10. Glycolytic inhibitor, 2-deoxy-D-glucose, does not enhance radiation-induced apoptosis in mouse thymocytes and splenocytes in vitro.
Swamy RK; Manickam J; Adhikari JS; Dwarakanath BS
Indian J Exp Biol; 2005 Aug; 43(8):686-92. PubMed ID: 16121709
[TBL] [Abstract][Full Text] [Related]
11. Modification of radiation damage in transformed mammalian cells by 5-bromo-2-deoxy-uridine and 2-deoxy-D-glucose.
Kalia VK; Jain V
Indian J Exp Biol; 1993 Mar; 31(3):224-30. PubMed ID: 8500838
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
Dwarkanath BS; Zolzer F; Chandana S; Bauch T; Adhikari JS; Muller WU; Streffer C; Jain V
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1051-61. PubMed ID: 11429233
[TBL] [Abstract][Full Text] [Related]
13. Effects of 5-bromo-2-deoxy-uridine and 2-deoxy-D-glucose on the radiosensitivity of proliferating transformed mammalian cells.
Kalia VK; Jain V
Indian J Exp Biol; 1991 Sep; 29(9):826-30. PubMed ID: 1794865
[TBL] [Abstract][Full Text] [Related]
14. Optimizing radiation therapy of brain tumours by combination of 5-bromo-2-deoxy-uridine & 2-deoxy-D-glucose.
Kalia VK
Indian J Med Res; 1999 May; 109():182-7. PubMed ID: 10643143
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro.
Dwarakanath BS
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S27-31. PubMed ID: 20009290
[TBL] [Abstract][Full Text] [Related]
16. 2-deoxy-D-glucose enhances the cytotoxicity of topoisomerase inhibitors in human tumor cell lines.
Dwarakanath BS; Khaitan D; Ravindranath T
Cancer Biol Ther; 2004 Sep; 3(9):864-70. PubMed ID: 15254410
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitization by 2-deoxy-D-glucose and 6-aminonicotinamide involves activation of redox sensitive ASK1-JNK/p38MAPK signaling in head and neck cancer cells.
Sharma PK; Dwarakanath BS; Varshney R
Free Radic Biol Med; 2012 Oct; 53(7):1500-13. PubMed ID: 22824861
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of pentose cycle of A549 cells by 6-aminonicotinamide: consequences for aerobic and hypoxic radiation response and for radiosensitizer action.
Varnes ME
NCI Monogr; 1988; (6):199-203. PubMed ID: 2965307
[TBL] [Abstract][Full Text] [Related]
19. Short-term exposure of multicellular tumor spheroids of a human glioma cell line to the glycolytic inhibitor 2-deoxy-D-glucose is more toxic than continuous exposure.
Khaitan D; Chandna S; Dwarakanath SB
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S67-73. PubMed ID: 20009299
[TBL] [Abstract][Full Text] [Related]
20. 2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism.
Lin X; Zhang F; Bradbury CM; Kaushal A; Li L; Spitz DR; Aft RL; Gius D
Cancer Res; 2003 Jun; 63(12):3413-7. PubMed ID: 12810678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
